Media Coverage

Optimizing Assay Development

Multichannel pipette injecting liquid into a microtiter plate

Biocompare

Assays are integral to successful and cost-effective drug discovery but optimizing them is no easy task. Biocompare asked David Cronk, Director, High-Throughput Screening Sciences, Charles River Laboratories, to walk us through some of the challenges in assay development and how his company is solving them; to discuss the role of automation in assay development and the benefits of using a service provider; and to share his insights for the future including thoughts on technological advances that could upend the industry. Finally, as a bonus, he threw in five expert tips on optimizing development of robust and reliable assays.

Read Full Q&A Session